Additionally, FAK overexpression evaluated by IHC has been correlated with increased lymph node metastasis, more advanced disease stages, and poor prognosis in a study of 153 patients with stage I–III NSCLC [19]. Here, PTK2 is linked to non-small cell lung carcinoma.